Abbvie Inc at Barclays Global Healthcare Conference Transcript
My pleasure to welcome AbbVie to the stage. No shortage of debates and controversies and launches going on. So thank you, AbbVie, for joining. Joining us from the company, Robert Michael, Vice Chairman and President; Scott Reents, CFO; Jeff Stewart, Chief Commercial Officer; as well as Roopal Thakkar, Development and Regulatory Affairs and CML.
Thank you Rob and team.
Thanks for having us.
Questions & Answers
Great. So we're going to just jump right into Q&A. Aesthetics has been sort of top of mind for many folks. And so I thought we'd start there. I think the company flagged uncertainty around some of the trends in the space, dating back to last year and certainly at the 4Q call. You've also referenced some stabilization in those metrics. So I guess the question is sort of what are you seeing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |